Report copyright - Should the therapy of AML be driven by MRD quantification? · AML02: A prospective, multicenter study of risk/MRD-directed therapy MRD monitored by FCM in 95% of pts MRD+: ≥ 0.1%
Please pass captcha verification before submit form
Please pass captcha verification before submit form